247 related articles for article (PubMed ID: 25967390)
1. Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
Shagisultanova E; Gaponova AV; Gabbasov R; Nicolas E; Golemis EA
Gene; 2015 Aug; 567(1):1-11. PubMed ID: 25967390
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.
Singh M; Cowell L; Seo S; O'Neill G; Golemis E
Cell Biochem Biophys; 2007; 48(1):54-72. PubMed ID: 17703068
[TBL] [Abstract][Full Text] [Related]
3. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.
Dai J; Van Wie PG; Fai LY; Kim D; Wang L; Poyil P; Luo J; Zhang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():106-112. PubMed ID: 27664007
[TBL] [Abstract][Full Text] [Related]
5. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
6. Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9.
Singh MK; Izumchenko E; Klein-Szanto AJ; Egleston BL; Wolfson M; Golemis EA
Cancer Res; 2010 Nov; 70(21):8907-16. PubMed ID: 20940402
[TBL] [Abstract][Full Text] [Related]
7. Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members.
Deneka A; Korobeynikov V; Golemis EA
Gene; 2015 Oct; 570(1):25-35. PubMed ID: 26119091
[TBL] [Abstract][Full Text] [Related]
8. NEDD9 depletion destabilizes Aurora A kinase and heightens the efficacy of Aurora A inhibitors: implications for treatment of metastatic solid tumors.
Ice RJ; McLaughlin SL; Livengood RH; Culp MV; Eddy ER; Ivanov AV; Pugacheva EN
Cancer Res; 2013 May; 73(10):3168-80. PubMed ID: 23539442
[TBL] [Abstract][Full Text] [Related]
9. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
10. Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity.
Bui LC; Tomkiewicz C; Chevallier A; Pierre S; Bats AS; Mota S; Raingeaud J; Pierre J; Diry M; Transy C; Garlatti M; Barouki R; Coumoul X
Oncogene; 2009 Oct; 28(41):3642-51. PubMed ID: 19648964
[TBL] [Abstract][Full Text] [Related]
11. NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
Gabbasov R; Xiao F; Howe CG; Bickel LE; O'Brien SW; Benrubi D; Do TV; Zhou Y; Nicolas E; Cai KQ; Litwin S; Seo S; Golemis EA; Connolly DC
Oncogene; 2018 Aug; 37(35):4854-4870. PubMed ID: 29773902
[TBL] [Abstract][Full Text] [Related]
12. Human enhancer of filamentation 1-induced colorectal cancer cell migration: Role of serine phosphorylation and interaction with the breast cancer anti-estrogen resistance 3 protein.
Ibrahim R; Lemoine A; Bertoglio J; Raingeaud J
Int J Biochem Cell Biol; 2015 Jul; 64():45-57. PubMed ID: 25817040
[TBL] [Abstract][Full Text] [Related]
13. A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.
O'Neill GM; Seo S; Serebriiskii IG; Lessin SR; Golemis EA
Cancer Res; 2007 Oct; 67(19):8975-9. PubMed ID: 17908996
[TBL] [Abstract][Full Text] [Related]
14. NEDD9 promotes oncogenic signaling in mammary tumor development.
Izumchenko E; Singh MK; Plotnikova OV; Tikhmyanova N; Little JL; Serebriiskii IG; Seo S; Kurokawa M; Egleston BL; Klein-Szanto A; Pugacheva EN; Hardy RR; Wolfson M; Connolly DC; Golemis EA
Cancer Res; 2009 Sep; 69(18):7198-206. PubMed ID: 19738060
[TBL] [Abstract][Full Text] [Related]
15. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
[TBL] [Abstract][Full Text] [Related]
16. NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation.
Tikhmyanova N; Golemis EA
PLoS One; 2011; 6(7):e22102. PubMed ID: 21765937
[TBL] [Abstract][Full Text] [Related]
17. Roles of neural precursor cell expressed, developmentally downregulated 9 in tumor-associated cellular processes (Review).
Zhang S; Wu L
Mol Med Rep; 2015 Nov; 12(5):6415-21. PubMed ID: 26324022
[TBL] [Abstract][Full Text] [Related]
18. HEF1-dependent Aurora A activation induces disassembly of the primary cilium.
Pugacheva EN; Jablonski SA; Hartman TR; Henske EP; Golemis EA
Cell; 2007 Jun; 129(7):1351-63. PubMed ID: 17604723
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinical significance of NEDD9 in lung tissues.
Chang JX; Gao F; Zhao GQ; Zhang GJ
Med Oncol; 2012 Dec; 29(4):2654-60. PubMed ID: 22447485
[TBL] [Abstract][Full Text] [Related]
20. Estradiol stabilizes the 105-kDa phospho-form of the adhesion docking protein NEDD9 and suppresses NEDD9-dependent cell spreading in breast cancer cells.
Bradshaw LN; Zhong J; Bradbury P; Mahmassani M; Smith JL; Ammit AJ; O'Neill GM
Biochim Biophys Acta; 2011 Feb; 1813(2):340-5. PubMed ID: 21145356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
